225 related articles for article (PubMed ID: 17009962)
21. The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b.
Yamashita K; Suzuki A; Satoh Y; Ide M; Amano Y; Masuda-Hirata M; Hayashi YK; Hamada K; Ogata K; Ohno S
Biochem Biophys Res Commun; 2010 Jan; 391(1):812-7. PubMed ID: 19945424
[TBL] [Abstract][Full Text] [Related]
22. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.
Schofield JN; Górecki DC; Blake DJ; Davies K; Edwards YH
Dev Dyn; 1995 Oct; 204(2):178-85. PubMed ID: 8589441
[TBL] [Abstract][Full Text] [Related]
23. Interdomain Linker Determines Primarily the Structural Stability of Dystrophin and Utrophin Tandem Calponin-Homology Domains Rather than Their Actin-Binding Affinity.
Bandi S; Singh SM; Mallela KM
Biochemistry; 2015 Sep; 54(35):5480-8. PubMed ID: 26288220
[TBL] [Abstract][Full Text] [Related]
24. Direct interaction of beta-dystroglycan with F-actin.
Chen YJ; Spence HJ; Cameron JM; Jess T; Ilsley JL; Winder SJ
Biochem J; 2003 Oct; 375(Pt 2):329-37. PubMed ID: 12892561
[TBL] [Abstract][Full Text] [Related]
25. Spatial relationship of the C-terminal domains of dystrophin and beta-dystroglycan in cardiac muscle support a direct molecular interaction at the plasma membrane interface.
Stevenson S; Rothery S; Cullen MJ; Severs NJ
Circ Res; 1998 Jan 9-23; 82(1):82-93. PubMed ID: 9440707
[TBL] [Abstract][Full Text] [Related]
26. Flexibility in the N-terminal actin-binding domain: clues from in silico mutations and molecular dynamics.
Chakravarty D; Chakraborti S; Chakrabarti P
Proteins; 2015 Apr; 83(4):696-710. PubMed ID: 25620004
[TBL] [Abstract][Full Text] [Related]
27. Structural comparison of actin binding in utrophin and dystrophin.
Keep NH
Neurol Sci; 2000; 21(5 Suppl):S929-37. PubMed ID: 11382192
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.
Singh SM; Molas JF; Kongari N; Bandi S; Armstrong GS; Winder SJ; Mallela KM
Proteins; 2012 May; 80(5):1377-92. PubMed ID: 22275054
[TBL] [Abstract][Full Text] [Related]
29. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
[TBL] [Abstract][Full Text] [Related]
30. The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.
Ilsley JL; Sudol M; Winder SJ
Cell Signal; 2001 Sep; 13(9):625-32. PubMed ID: 11495720
[TBL] [Abstract][Full Text] [Related]
31. In vitro developmental expression of dystroglycan and laminin-alpha2 in human skeletal muscle.
Chen L; Burgunder JM
Cell Biol Int; 2005 Jul; 29(7):506-13. PubMed ID: 15982904
[TBL] [Abstract][Full Text] [Related]
32. Distinct mechanical properties in homologous spectrin-like repeats of utrophin.
Rajaganapathy S; McCourt JL; Ghosal S; Lindsay A; McCourt PM; Lowe DA; Ervasti JM; Salapaka MV
Sci Rep; 2019 Mar; 9(1):5210. PubMed ID: 30914715
[TBL] [Abstract][Full Text] [Related]
33. Identification of new dystroglycan complexes in skeletal muscle.
Johnson EK; Li B; Yoon JH; Flanigan KM; Martin PT; Ervasti J; Montanaro F
PLoS One; 2013; 8(8):e73224. PubMed ID: 23951345
[TBL] [Abstract][Full Text] [Related]
34. The 2.0 A structure of the second calponin homology domain from the actin-binding region of the dystrophin homologue utrophin.
Keep NH; Norwood FL; Moores CA; Winder SJ; Kendrick-Jones J
J Mol Biol; 1999 Jan; 285(3):1257-64. PubMed ID: 9887274
[TBL] [Abstract][Full Text] [Related]
35. The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy.
Norwood FL; Sutherland-Smith AJ; Keep NH; Kendrick-Jones J
Structure; 2000 May; 8(5):481-91. PubMed ID: 10801490
[TBL] [Abstract][Full Text] [Related]
36. Interactions between dystrophin and the sarcolemma membrane.
Chamberlain JS; Corrado K; Rafael JA; Cox GA; Hauser M; Lumeng C
Soc Gen Physiol Ser; 1997; 52():19-29. PubMed ID: 9210217
[TBL] [Abstract][Full Text] [Related]
37. Alterations of the perivascular dystrophin-dystroglycan complex following brain lesions: an immunohistochemical study in rats.
Kálmán M; Mahalek J; Adorján A; Adorján I; Pócsai K; Bagyura Z; Sadeghian S
Histol Histopathol; 2011 Nov; 26(11):1435-52. PubMed ID: 21938681
[TBL] [Abstract][Full Text] [Related]
38. Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells.
Draviam RA; Wang B; Li J; Xiao X; Watkins SC
J Muscle Res Cell Motil; 2006; 27(1):53-67. PubMed ID: 16496225
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K; Di Stasio E; Macchia G; Rosa G; Brancaccio A; Petrucci TC
Biochem Biophys Res Commun; 2000 Jul; 274(1):93-8. PubMed ID: 10903901
[TBL] [Abstract][Full Text] [Related]
40. Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.
Cerecedo D; Cisneros B; Gómez P; Galván IJ
Exp Hematol; 2010 Aug; 38(8):618-628.e3. PubMed ID: 20434517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
